ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 9 filers reported holding ESSA PHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $73 | – | 27 | -76.1% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 113 | -99.3% | 0.00% | – |
| Q3 2022 | $30,000 | -56.5% | 16,760 | -23.7% | 0.00% | -100.0% |
| Q2 2022 | $69,000 | +2200.0% | 21,968 | +4728.1% | 0.00% | – |
| Q1 2022 | $3,000 | -40.0% | 455 | +29.6% | 0.00% | – |
| Q4 2021 | $5,000 | -90.9% | 351 | -94.9% | 0.00% | -100.0% |
| Q3 2021 | $55,000 | – | 6,890 | +7641.6% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 89 | -55.5% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 200 | -50.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 400 | +100.0% | 0.00% | – |
| Q2 2018 | $1,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,145,117 | $12,310,997 | 1.28% |
| BVF INC/IL | 8,748,629 | $25,983,428 | 0.95% |
| Ally Bridge Group (NY) LLC | 236,583 | $702,652 | 0.92% |
| PFM Health Sciences, LP | 4,161,461 | $12,359,539 | 0.55% |
| Bellevue Group AG | 7,898,583 | $23,458,792 | 0.34% |
| Rhenman & Partners Asset Management AB | 356,500 | $1,051,675 | 0.12% |
| Orbimed Advisors | 1,198,337 | $3,559,061 | 0.07% |
| Privium Fund Management (UK) Ltd | 20,032 | $61,498 | 0.05% |
| Rock Springs Capital Management LP | 524,944 | $1,559,084 | 0.04% |
| Hunting Hill Global Capital, LLC | 10,000 | $29,700 | 0.02% |